Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natrecor (Nesiritide) Versus Dobutamine Therapy for Symptomatic, Decompensated CHF: A Safety Study Using 24-Hour Holter Monitoring - The PRECEDENT Trial: Prospective, Randomized Evaluation of Cardiac Ectopy With Dobutamine or Natrecor Therapy

NCT00270400 is registered in ClinicalTrials.gov with Scios, Inc. as lead sponsor.

NCT NCT00270400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00270400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natrecor (Nesiritide) Versus Dobutamine Therapy for Symptomatic, Decompensated CHF: A Safety Study Using 24-Hour Holter Monitoring - The PRECEDENT Trial: Prospective, Randomized Evaluation of Cardiac Ectopy With Dobutamine or Natrecor Therapy
Lead sponsor
Scios, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 1998
Completion date
February 28, 1999
Enrollment
255 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive